Bone Marrow Transplantation in Patients with Gold‐Induced Marrow Aplasia
Open Access
- 1 June 1977
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 20 (5) , 1043-1048
- https://doi.org/10.1002/art.1780200502
Abstract
Aplastic anemia is a rare but usually fatal complication of gold salt therapy for rheumatoid arthritis. This report describes 3 patients who developed aplastic anemia while receiving gold salts, and a fourth patient who developed aplastic anemia after receiving gold and then cytotoxic agents. These patients failed to respond to conventional therapy for aplastic anemia and subsequently received bone marrow transplants from HLA‐matched siblings. Engraftment occurred in all 4 patients. One patient is alive 2 years after transplantation, and 3 patients died of complications following transplantation.This publication has 20 references indexed in Scilit:
- Letter: Chronic thrombocytopenia following gold therpayArchives of internal medicine (1960), 1975
- Letter: Chronic thrombocytopenia following gold therapyArchives of internal medicine (1960), 1975
- Gold-associated thrombocytopenia. Report six casesArchives of internal medicine (1960), 1974
- Significance of eosinophilia during gold therapyArthritis & Rheumatism, 1974
- Death after Taking MedicamentsBMJ, 1974
- Immunological Studies on the Mechanism of Gold Hypersensitivity ReactionsBMJ, 1973
- Gold metabolism in patients with rheumatoid arthritis treated with gold compounds—reinvestigatedArthritis & Rheumatism, 1972
- Gold-induced thrombocytopenia and response to dimercaprol.BMJ, 1972
- Gold in rheumatoid arthritis.BMJ, 1971
- Fatality Due to the Use of GoldBMJ, 1954